These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 37019589)

  • 1. Epigenetics in cardiovascular health and disease.
    Chew NWS; Loong SSE; Foo R
    Prog Mol Biol Transl Sci; 2023; 197():105-134. PubMed ID: 37019589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of Epigenetic Control and Non-coding RNAs in Cardiovascular System.
    Sharma S; Mishra A; Ashraf MZ
    Adv Exp Med Biol; 2020; 1229():121-132. PubMed ID: 32285408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic Regulation of Autophagy in Cardiovascular Pathobiology.
    Bu S; Singh KK
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of epigenetics on cardiovascular disease.
    Prasher D; Greenway SC; Singh RB
    Biochem Cell Biol; 2020 Feb; 98(1):12-22. PubMed ID: 31112654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic-related therapeutic challenges in cardiovascular disease.
    Schiano C; Vietri MT; Grimaldi V; Picascia A; De Pascale MR; Napoli C
    Trends Pharmacol Sci; 2015 Apr; 36(4):226-35. PubMed ID: 25758254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation of sex dimorphism in cardiovascular health.
    Thej C; Kishore R
    Can J Physiol Pharmacol; 2024 Sep; 102(9):498-510. PubMed ID: 38427976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential regulatory role of epigenetic RNA methylation in cardiovascular diseases.
    Komal S; Zhang LR; Han SN
    Biomed Pharmacother; 2021 May; 137():111376. PubMed ID: 33588266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergent expansion of clinical epigenetics in patients with cardiovascular diseases.
    Napoli C; Coscioni E; de Nigris F; Donatelli F
    Curr Opin Cardiol; 2021 May; 36(3):295-300. PubMed ID: 33605616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of redox signaling in epigenetics and cardiovascular disease.
    Kim GH; Ryan JJ; Archer SL
    Antioxid Redox Signal; 2013 May; 18(15):1920-36. PubMed ID: 23480168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Potential of Natural Compounds Acting through Epigenetic Mechanisms in Cardiovascular Diseases: Current Findings and Future Directions.
    Bontempo P; Capasso L; De Masi L; Nebbioso A; Rigano D
    Nutrients; 2024 Jul; 16(15):. PubMed ID: 39125279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic-sensitive pathways in personalized therapy of major cardiovascular diseases.
    Schiano C; Benincasa G; Franzese M; Della Mura N; Pane K; Salvatore M; Napoli C
    Pharmacol Ther; 2020 Jun; 210():107514. PubMed ID: 32105674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac epigenetics: Driving signals to the cardiac epigenome in development and disease.
    Robinson EL; Anene-Nzelu CG; Rosa-Garrido M; Foo RSY
    J Mol Cell Cardiol; 2021 Feb; 151():88. PubMed ID: 33232681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic associations in relation to cardiovascular prevention and therapeutics.
    Voelter-Mahlknecht S
    Clin Epigenetics; 2016; 8():4. PubMed ID: 26779291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From Waddington's epigenetic landscape to small noncoding RNA: some important milestones in the history of epigenetics research.
    Choudhuri S
    Toxicol Mech Methods; 2011 May; 21(4):252-74. PubMed ID: 21495865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The involvement of epigenetics in vascular disease development.
    Elia L; Condorelli G
    Int J Biochem Cell Biol; 2019 Feb; 107():27-31. PubMed ID: 30543933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of epigenetics in the management of cardiovascular disease: a review.
    Cao Y; Lu L; Liu M; Li XC; Sun RR; Zheng Y; Zhang PY
    Eur Rev Med Pharmacol Sci; 2014 Oct; 18(20):3097-104. PubMed ID: 25392111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of cardiovascular pathology with epigenetically active agents: Focus on natural and synthetic inhibitors of DNA methylation and histone deacetylation.
    Chistiakov DA; Orekhov AN; Bobryshev YV
    Int J Cardiol; 2017 Jan; 227():66-82. PubMed ID: 27852009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics.
    Xu S; Kamato D; Little PJ; Nakagawa S; Pelisek J; Jin ZG
    Pharmacol Ther; 2019 Apr; 196():15-43. PubMed ID: 30439455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetics in the development, modification, and prevention of cardiovascular disease.
    Whayne TF
    Mol Biol Rep; 2015 Apr; 42(4):765-76. PubMed ID: 25205125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular epigenetics: from DNA methylation to microRNAs.
    Udali S; Guarini P; Moruzzi S; Choi SW; Friso S
    Mol Aspects Med; 2013; 34(4):883-901. PubMed ID: 22981780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.